Anti-CD20 Monoclonal Antibodies | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

24,850 results for “Anti-CD20 Monoclonal Antibodies”

Trials

View all 11892 →

Rehabilitative Protocols in Progressive Multiple Sclerosis Treated with Anti CD20 Monoclonal Antibodies

82 participants · First posted Mar 25, 2025

FT596 as a Monotherapy and in Combination With Anti-CD20 Monoclonal Antibodies

98 participants · First posted Jan 29, 2020

Specific Anti-HBV Vaccine Response After Vaccination in Patients Requiring Anti-CD20 Monoclonal Antibodies

60 participants · First posted Aug 20, 2020

Drugs

View all 4435 →

Anti-CD20 monoclonal antibodies(BASF Corp.)

anti-RAGE monoclonal antibodies

anti-tau monoclonal antibodies

Organizations

View all 105 →

ImmunoPrecise Antibodies

Canada

Novel Anti-Infective Technologies, LLC

AiCuris Anti-Infective Cures AG

Germany

News

View all 8418 →

ACROBiosystems and SeromYx Systems Partner to Advance Anti-CD20 Monoclonal Antibody Research Through Comprehensive Functional Profiling

Bio-Thera's BAT4406F Shows Promise in Neuromyelitis Optica Spectrum Disorders

Rituxan Approved in Japan for Pediatric Chronic ITP

Page 1 of 2485